Compositions comprising HIV envelopes to induce CH235 lineage antibodies
US10968255B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 1, 2017 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Mar 1, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In certain aspects the invention provides HIV-1 immunogens, including HIV-1 envelope selections from individual CH505, and methods for swarm immunizations using combinations of HIV-1 envelopes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.